Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAVMET: Maraviroc and/or Metformin for Hepatic Steatosis in HIV
NCT03129113Phase 3Completed
- Sponsor
- University College London
- Start
- Mar 2017
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of maraviroc, metformin in hepatic steatosis, sponsored by University College London. Started Mar 2017; status: completed.
02
Drugs
maravirocmetformin
03
Conditions
hepatic steatosis
Beyond the preview
Go deeper on NCT03129113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03129113.